PRA


Also found in: Dictionary, Thesaurus, Financial, Acronyms, Encyclopedia, Wikipedia.

PRA

Abbreviation for plasma renin activity; phosphoribosylamine.

PRA

panel-reactive antibody.

plasma renin assay (PRA)

a blood test that measures the rate of generation of angiotensin. The most commonly used renin assay, it is a screening procedure for detecting essential, renal, or renovascular hypertension, and it is also performed to diagnose and separate primary from secondary hyperaldosteronism.

S100A6

A gene on chromosome 1q21 that encodes a member of the S100 family of proteins, which have 2 EF-hand calcium-binding motifs. S100 proteins are localised in the cytoplasm and/or nucleus of a wide range of cells; they are involved in regulating cell cycle progression, differentiation and other intracellular activities. S100A6 is thought to play a role in stimulating Ca2+-dependent insulin release, stimulating prolactin secretion, and exocytosis.

PRA

1. Plasma renin activity.

PRA

Abbreviation for plasma renin activity.

antibody

(ant'i-bod?e) [ anti- + body],

Ab

Enlarge picture
ANTIBODY: Structure of one igG molecule
A substance produced by B lymphocytes in response to a unique antigen. Each Ab molecule combines with a specific antigen to destroy or control it. All antibodies, except natural antibodies (antibodies to different blood types), are made by B cells stimulated by a foreign antigen, typically a foreign protein, polysaccharide, or nucleic acid. Synonym: immunoglobulin See: illustration; antigen; autoantibody; cytokine; isoantibody

Antibodies neutralize or destroy antigens in several ways. They can initiate lysis of the antigen by activating the complement system; neutralize toxins released by bacteria, coating (opsonizing) the antigen or forming a complex to stimulate phagocytosis; promote antigen clumping (agglutination); or prevent the antigen from adhering to host cells.

An antibody molecule consists of four polypeptide chains (two light and two heavy), which are joined by disulfide bonds. The heavy chains form the complement-binding site, and the light and heavy chains form the site that binds the antigen.

Enlarge picture
ASCARIS LUMBRICOIDES

acetylcholine receptor binding antibody

Abbreviation: AChR-Ab
An autoantibody against acetylcholine receptors in the neuromuscular junction. Binding, blocking, or modulating antibodies against this receptor are found in the blood of most patients with generalized myasthenia gravis and in about half of all patients with ocular forms of the disease.
illustration

agonistic antibody

An antibody that stimulates or activates an organ. E.g., agonistic antibodies against the thyrotropin receptor in Grave disease stimulate the thyroid gland to release thyroid hormones that produce hyperthyroidism.

anticardiolipin antibody

Abbreviation: aCLa
An autoantibody against the cell membrane lipid, diphosphatidyl glycerol. It produces abnormal and sometimes life-threatening blood clotting. The antibody is found in a variety of autoimmune and infectious diseases, including in patients with the antiphospholipid antibody syndrome and syphilis.

anticyclic citrullinated peptide antibody

Abbreviation: anti-CCP
An antibody found in the serum of patients with rheumatoid arthritis but not in those with other joint or soft tissue diseases.

anti–DNase B antibody

An antibody formed during infection with group A beta-hemolytic streptococci. It is used, retrospectively, to help diagnose recent streptococcal infections.

antiendomysial antibody

An antibody that cross-reacts with smooth muscle collagen and the gluten in wheat, found in the serum of people with celiac sprue and some related autoimmune diseases.

antiendothelial cell antibody

An autoantibody present in the serum of patients with a variety of autoimmune diseases, including scleroderma (systemic sclerosis), systemic lupus erythematosus, interstitial lung diseases, and sarcoidosis. They attach to antigens on the cells that line blood vessels and injure those cells, producing blood vessel injury and inflammation (vasculitis).

antifibrillarin antibody

An autoantibody to the nucleolar protein fibrillarin, found in patients with diffuse systemic sclerosis (scleroderma), esp. those with relatively severe disease. It is identified more often in men than in women with the disease and in people of African descent as opposed to Europeans or Asians.

antiganglioside antibody

An antibody formed against the chemical components of nerves, found in the serum of those with Guillain-Barré syndrome.

antigliadin antibody

An antibody formed against the gluten in wheat, found in the serum of people with celiac sprue.

antileukocyte antibody

Any antibody found in plasma that, when donated and infused into a recipient, damages the recipient's white blood cells. Leukocyte injury after plasma exchange or infusion is the event that triggers transfusion-related acute lung injury.

anti-Hu antibody

An autoantibody associated with paraneoplastic encephalomyelitis. It is also known as ANNA-1 (antineuronal nuclear antibody-1).

antimicrosomal antibody

An autoantibody found in the plasma of patients with thyroid injury, e.g., in several forms of thyroiditis and other rheumatologic or autoimmune diseases.

anti-myeloperoxidase antibody

An antibody found in patients with several autoimmune vasculitides, such as microscopic polyangitis.
Synonym: perinuclear anti–neutrophil cytoplasmic antibody

antineuronal nuclear antibody

Abbreviation: ANNA
Any of several antibodies that bind to neuronal targets in the cerebrum and cerebellum, producing paraneoplastic neurological dysfunction. The antibodies are typically released by cancers such as small-cell carcinoma of the lung (also known as ANNA-1 and ANNA-2), testicular cancer (anti-Ta antibody), or breast cancer (ANNA-2).

antineutrophil cytoplasmic antibody

Abbreviation: ANCA
An autoantibody found in the blood of patients with certain forms of vasculitis (such as Churg-Strauss syndrome, microscopic polyangiitis, Wegener granulomatosis) esp. when it affects small blood vessels.

antinuclear antibody

Abbreviation: ANA
Any of a group of autoantibodies that react against normal components of the cell nucleus. These antibodies are present in a variety of immunologic diseases, including systemic lupus erythematosus, progressive systemic sclerosis, Sjögren syndrome, scleroderma, polymyositis, and dermatomyositis, and in some patients taking hydralazine, procainamide, or isoniazid. In addition, ANA is present in some normal people. Tests for ANAs are used in the diagnosis and management of autoimmune diseases.

antiphospholipid antibody

Abbreviation: aPLa
Any of a group of immunoglobulin autoantibodies that react with phospholipids, which are one of the primary components of the cell membrane (the other components are glycolipids and steroids). These antibodies are found in patients with a variety of connective tissue and infectious disorders, including systemic lupus erythematosus, the antiphospholipid antibody syndrome, syphilis, and malaria. They cause abnormal blood clotting, thrombocytopenia; and in women of childbearing age, repeated miscarriages. The anticardiolipin antibodies are one type of antiphospholipid antibody.

anti–proliferating cell nuclear antigen (PCNA) antibody

Abbreviation: anti-PCNA
An antibody found in the blood of patients with diseases in which cells replicate rapidly. Such conditions include autoimmune and inflammatory diseases and malignancies.

antiproteinase-3 antibody

An autoantibody found in patients with small blood vessel vasculitides, such as Wegener granulomatosis.
Synonym: diffusely cytoplasmic anti–neutrophil antibody

antireceptor antibody

An antibody that reacts with the antigen receptor on a cell rather than with an antigen itself.

antiribosomal P antibody

An autoantibody found in patients with systemic lupus erythematosus, esp. those with neurological or psychiatric manifestations of the disorder.

anti-scl-70 antibody

Anti-topoisomerase I antibody.

antithyroperoxidase antibody

Abbreviation: TPOAb
A serum marker of autoimmune thyroid destruction, i.e., of Grave disease or Hashimotothyroiditis.

antititin antibody

An antibody that reacts with striated muscle cells. It is found principally in people with myasthenia gravis who also have thymoma.

anti-topoisomerase I antibody

An autoantibody found in the serum of patients with progressive systemic sclerosis, silicosis, and systemic lupus erythematosus. Higher levels of the antibody correlate with worsening kidney, lung, and skin disease.
Synonym: anti-scl-70 antibody

blocking antibody

An antibody that prevents an antigen from binding with a cellular receptor.

catalytic antibody

Abzyme.

cross-reacting antibody

An antibody that reacts with antigens other than its specific antigen because they contain binding sites that are structurally similar to its specific antigen.
See: antigenic determinant

cytotoxic antibody

An antibody that lyses cells by binding to a cellular antigen and activating complement or killer cells.

diffusely cytoplasmic anti-neutrophil cytoplasmic antibody

Abbreviation: C-ANCA.
Antiproteinase-3 antibody.

direct fluorescein-conjugated antibody

Abbreviation: DFA
Direct fluorescent antibody.

direct fluorescent antibody

Abbreviation: DFA
A fluorescent antibody test performed on sputum to detect microorganisms that invade the respiratory tract, e.g., Legionella, Mycoplasma, or Bacillus anthracis.
Synonym: direct fluorescein-conjugated antibody; direct immunofluorescence test

Donath-Landsteiner antibody

See: Donath-Landsteiner antibody

fluorescent antibody

Abbreviation: FA
An antibody that has been stained or marked by a fluorescent material. The fluorescent antibody technique permits rapid diagnosis of various infections.

glutamic acid decarboxylase antibody

Abbreviation: GADA
An antibody to glutamic acid decarboxylase. It is a serum marker of type 1 diabetes mellitus and is found in the blood of patients with stiff-person syndrome.

immune antibody

An antibody produced by immunization or as a result of transfusion of incompatible blood.

maternal antibody

An antibody produced by the mother and transferred to the fetus in utero or during breastfeeding.

monoclonal antibody

Abbreviation: MoAB
A type of antibody, specific to a certain antigen, created in the laboratory from hybridoma cells. Because monoclonal antibodies are derived from a single cell line and raised against a single antigen, they are highly specific. Diagnostically, they are used to identify microorganisms, white blood cells, hormones, and tumor antigens. In patient care, they are used to treat transplant rejection, certain cancers, and autoimmune diseases.

Hybridoma cells, used to produce monoclonal antibodies, are formed by the fusion of a spleen cell from a mouse immunized with an antigen and a multiple myeloma cell (a cancerous plasma B cell). The fused cells are screened to identify those that secrete antibodies against a specific antigen. A continuous supply of these antigen-specific monoclonal antibody secreting cells can then be grown in cultures.

See: antibody; B cell; hybridoma

natural antibody

An antibody present in a person without known exposure to the specific antigen, such as an anti-A antibody in a person with B blood type.

panel reactive antibody

Abbreviation: PRA
A measure of an organ transplant recipient's level of sensitization to antigens on donated organs. It is the percentage of cells taken from a broad selection of blood donors against whose antigens the organ recipient's serum reacts. The higher the panel reactive antibody, the more challenging it is to match a donor organ to the recipient.

perinuclear antineutrophil cytoplasmic antibody

Antimyeloperoxidase antibody.

p504s antibody

Alpha-methylacyl-CoA racemase.

polyclonal antibody

An antibody that reacts with many different antigens.

protective antibody

An antibody produced in response to an infectious disease. See: immunity

radionuclide-linked monoclonal antibody

A monoclonal antibody to which a radioisotope has been attached. The antibody attaches to receptors on the surface of undesired cells (e.g., cancer cells) and delivers a dose of radiation directly to those cells, leaving healthy cells and tissues relatively unaffected.

sensitizing antibody

Reagin.

toxin-linked monoclonal antibody

A monoclonal antibody to which a cell-killing drug has been attached. The antibody combines preferentially with receptors on undesired cells (such as cancer cells) and delivers its lethal drug to those cells but not to healthy cells and tissues. To increase their effectiveness and decrease immune responses to these cells, genes for antigen binding sites from human antibodies are added, creating humanized monoclonal antibodies.

warm antibody

Warm autoagglutinin.illustration

panel reactive antibody

Abbreviation: PRA
A measure of an organ transplant recipient's level of sensitization to antigens on donated organs. It is the percentage of cells taken from a broad selection of blood donors against whose antigens the organ recipient's serum reacts. The higher the panel reactive antibody, the more challenging it is to match a donor organ to the recipient.
See also: antibody

PRA

progressive retinal atrophy.
References in periodicals archive ?
ABOUT PRA HEALTH SCIENCES At PRA Health Sciences, providing innovative solutions for our clients is what we do.
About PRA PRA is transforming clinical trials through our people, innovation and transparency.
This unique PRA philosophy recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to be innovative and to use their personal commitment to accelerate the development life cycle.
PRA performs studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases.
This program, dubbed "Build your Own Business" solutions by IBM, is targeting medium sized businesses that can leverage the BladeFusion SPE(TM) and PRA model to take full advantage of BladeFusion's commitment to 'S to the 4th Power': Survivability, Scalability, Serviceability and Security.
In addition, PRA had seven other finalists compete in the event.
At booth 11, PRA drug safety managers will be available to discuss PRA's successful experience in SRM engagements for sponsor.
May 21, 2012 /PRNewswire/ -- PRA, a leading Clinical Research Organization, announces the expansion of operations in The Netherlands (NL) and the United Kingdom (UK) to accommodate staff growth and strong client demand for our Phase IIa-IIIb service offerings.
RALEIGH, North Carolina, August 23, 2010 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, will exhibit our cardiology expertise and experience at the European Society of Cardiology's (ESC) annual conference in Stockholm, Sweden from 28 August to 1 September 2010.
of PRA International, was named Medical Monitor for the Phase ll colorectal cancer trial.
PRA will also host an exhibit at booth #4, where PRA representatives will be available to discuss our successful approach to drug development programs.
RALEIGH, North Carolina, January 15 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces that it will begin providing a client-facing portal into Oracle(R) Remote Data Capture (RDC) for its early phase studies in its Clinical Pharmacology Units in The Netherlands and the United States.